Atherogenesis is the process by which fatty, inflammatory plaques build up inside artery walls. It begins with subtle damage to the artery lining, progresses through decades of lipid accumulation and immune cell activity, and can ultimately lead to heart attacks and strokes when a plaque ruptures or narrows the artery enough to restrict blood flow. Symptoms typically don’t appear until an artery has lost about 70 to 75% of its opening.
How Atherogenesis Starts
The process kicks off at the endothelium, the single-cell-thick layer lining every artery. Under normal conditions, this lining produces nitric oxide, a molecule that keeps blood vessels relaxed and discourages blood cells from sticking. When the endothelium is stressed, nitric oxide production drops and the lining shifts into a pro-inflammatory state that sets the stage for everything that follows.
Three forces drive that initial stress. The first is disturbed blood flow. Arteries don’t experience uniform pressure everywhere. At branch points and curves, blood swirls and eddies instead of flowing smoothly. These turbulent zones experience low shear stress, which changes how endothelial cells behave, pushing them toward inflammation. This is why plaques tend to cluster at arterial forks rather than along straight segments. The second force is oxidative stress, where reactive molecules overwhelm the lining’s defenses and degrade nitric oxide before it can do its job. The third is chronic inflammation, often fueled by circulating cholesterol-carrying particles, smoking, high blood pressure, or elevated blood sugar. These three factors reinforce each other in a cycle: inflammation increases oxidative stress, oxidative stress reduces nitric oxide, and the resulting dysfunction invites more inflammation.
Lipid Trapping in the Artery Wall
Once the endothelium is compromised, cholesterol-carrying particles (primarily LDL) slip through into the space just beneath the artery lining. Getting in isn’t the real problem. The critical event is getting stuck. LDL particles bind to sugar-protein molecules called proteoglycans in the artery wall. The bond is essentially electrical: positively charged regions on the LDL protein latch onto negatively charged sulfate groups on the proteoglycans. Research from the American Heart Association describes this “response-to-retention” process as the central event in early atherogenesis, noting that retention, not simply increased entry of lipoproteins, is the key pathological step.
Once trapped, the particles undergo chemical changes. Enzymes in the artery wall break down components of the LDL surface, causing the particles to clump together and fuse into larger aggregates. These oversized clusters are physically too big to exit back through the artery wall, so they accumulate. The trapped LDL also becomes oxidized, transforming into a potent inflammatory signal that draws immune cells to the site.
Immune Cells and Foam Cell Formation
Oxidized LDL triggers endothelial cells to display sticky surface proteins called selectins and adhesion molecules. These act like molecular Velcro for passing immune cells, particularly monocytes (a type of white blood cell). The recruitment follows an orderly sequence: monocytes first roll along the activated endothelium, then are chemically signaled to slow down, and finally lock on firmly before squeezing through gaps between endothelial cells into the artery wall.
Once inside, monocytes mature into macrophages, immune cells whose normal job is to engulf debris and pathogens. These macrophages recognize oxidized LDL through specialized receptors on their surface, primarily two types known as CD36 and SR-A, which together account for 75 to 90% of modified LDL uptake. Unlike the body’s normal LDL receptors, these scavenger receptors have no off switch. The macrophages gorge on oxidized lipids without limit, swelling into bloated, lipid-packed cells called foam cells. Masses of foam cells visible under a microscope form what’s called a “fatty streak,” the earliest physical sign of atherosclerosis. Fatty streaks can appear in arteries as early as childhood and adolescence.
Smooth Muscle Cells Change Their Role
In a healthy artery, smooth muscle cells in the vessel wall maintain a contractile state, squeezing and relaxing to regulate blood flow. As atherogenesis progresses, signals from the inflamed plaque cause these cells to undergo a dramatic identity shift. They abandon their contractile function and switch to a “synthetic” state, gaining the ability to migrate, multiply, and produce structural proteins like collagen and elastin.
This transformation serves a dual purpose. On one hand, migrating smooth muscle cells form a protective fibrous cap over the growing plaque, walling it off from the bloodstream. On the other hand, their proliferation contributes to the thickening of the artery wall and narrowing of the vessel. The fibrous cap itself is made of layers of these reprogrammed smooth muscle cells embedded in a collagen and elastin matrix. Signals involving growth factors and specific cell-signaling pathways control how many smooth muscle cells enter the cap and whether they stay there. When these signals are disrupted, the cap forms poorly, leaving the plaque vulnerable.
The Necrotic Core and Plaque Progression
As the plaque matures, foam cells begin to die. In a healthy tissue, dead cells are quickly engulfed and recycled by neighboring cells through a cleanup process called efferocytosis. In advanced plaques, this cleanup system fails. Studies comparing advanced human plaques to healthy tissue with efficient cell clearance found significantly more uncleared dead cells in the plaques. When apoptotic (programmed-death) cells aren’t removed promptly, they undergo secondary necrosis, their membranes break open and spill inflammatory contents into the surrounding tissue.
This accumulating cellular debris, mixed with free cholesterol and lipid, forms the necrotic core: a soft, destabilizing mass at the center of the plaque. The necrotic core is a hallmark of advanced atherosclerosis. Once it forms, plaque regression becomes unlikely. The leaked contents of dead cells also trigger further inflammation, attracting more immune cells and accelerating a destructive cycle. Mouse studies in which genes involved in dead-cell clearance were deliberately disrupted consistently showed larger necrotic cores, confirming that failed cleanup is a primary driver of plaque progression.
What Makes a Plaque Dangerous
Not all plaques pose the same risk. The anatomy of a plaque determines whether it causes a gradual narrowing of the artery or a sudden, catastrophic event. Three features define a vulnerable, rupture-prone plaque: a large lipid core, a thin fibrous cap, and a high concentration of macrophages. Coronary plaques rarely rupture when the fibrous cap is thicker than 65 micrometers (roughly the width of a human hair). Solid fibrous plaques without a lipid core carry essentially no rupture risk.
What makes this especially dangerous is that the most rupture-prone plaques often don’t cause significant narrowing. A plaque can grow outward, remodeling the artery wall without restricting blood flow, yet still harbor a thin cap over a large necrotic core. When that cap tears, the contents of the core are exposed to the bloodstream, triggering a blood clot that can completely block the artery within minutes. This is the mechanism behind most heart attacks. Meanwhile, plaques that do cause severe narrowing (75% or greater stenosis) typically produce symptoms like chest pain during exertion or leg pain while walking, because the remaining opening is too small to deliver enough blood during physical activity.
Inflammation as a Continuous Driver
Inflammation isn’t just a trigger at the start. It is woven into every stage of atherogenesis. Oxidized LDL activates immune receptors on both endothelial cells and macrophages, sustaining a chronic inflammatory environment within the plaque. This ongoing inflammation weakens the fibrous cap by stimulating macrophages to release enzymes that break down collagen. It also promotes further immune cell recruitment, creating a self-perpetuating loop.
C-reactive protein (CRP), a blood marker of systemic inflammation, reflects this process. Levels above 3 mg/L are found in fewer than 10% of healthy people but in more than 65% of patients with unstable angina (a condition where plaques are actively threatening to rupture). In patients experiencing a heart attack preceded by unstable angina, over 90% have elevated CRP. This gradient illustrates how tightly inflammation tracks with plaque instability, and it’s one reason CRP testing has become a tool for assessing cardiovascular risk beyond traditional cholesterol numbers.
Timeline and Progression
Atherogenesis is exceptionally slow. Fatty streaks can appear in the aorta during childhood, with more advanced lesions developing over decades. The progression from fatty streak to fibrous plaque to a complex, rupture-prone lesion is not inevitable at every site, and many plaques remain stable for a lifetime. The process accelerates in the presence of sustained risk factors: high LDL cholesterol, smoking, high blood pressure, diabetes, and chronic inflammation. Removing or reducing these factors can slow progression and, in the case of early-stage disease, partially reverse lipid accumulation, though established necrotic cores are far more resistant to regression.